MIST Milestone Pharmaceuticals Inc.
$0.74▼ -6.64%
Healthcare
Other
Volume 531.3K
Avg Volume (10D) 819.7K
Key Metrics & Fundamentals
Market Cap
$91.78M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.63 - 3.06
% vs 50 MA
-12.09%
% vs 200 MA
-42.81%
RSI-14
51.0
MACD Histogram
+0.0100
Beta (1Y vs SPY)
2.53
Free Cash Flow
-$22.74M
Gross Rev
$559,000
Gross Profit
$527,000
EBITDA
-$23.83M
COGS
$32,000
Operating Exp
$26.16M
Operating Income
-$25.63M
EBIT
-$25.63M
Pretax Income
-$28.61M
Net Income
-$28.61M
EPS (Diluted)
-0.21
Price & Volume History
Loading chart…
Recent News
Milestone Pharmaceuticals (MIST) Stock Sees Fair Value Falls As Analysts Reset Cardamyst Expectations
Simply Wall St. · Oct 23, 2026 4:13 AM ET
Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences
GlobeNewswire · Oct 19, 2026 8:00 AM ET
Milestone Pharmaceuticals Enrolls First EU Patient in Phase 3 Etripamil Trial in Atrial Fibrillation
MT Newswires · Oct 9, 2026 8:43 AM ET
Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
GlobeNewswire · Oct 9, 2026 8:00 AM ET
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
GlobeNewswire · Sep 24, 2026 8:00 AM ET
Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
GlobeNewswire · Sep 3, 2026 9:35 AM ET
Milestone Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire · Sep 2, 2026 8:00 AM ET
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
GlobeNewswire · Aug 27, 2026 8:00 AM ET
Milestone Pharmaceuticals shares rise as first patient enters Phase 3 AFib trial
InvestorsHub · Aug 21, 2026 9:28 AM ET
Milestone Starts Phase 3 Trial of Nasal Spray for Atrial Fibrillation With Rapid Heart Rate
MT Newswires · Aug 21, 2026 8:34 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MIST's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.